Open AccessCompletely resected stage III melanoma controversy - 15 years of national tertiary centre experience
Author(s) -
Barbara Perić,
Sara Milićević,
Andraž Perhavec,
Marko Hočevar,
Janez Žgajnar
Publication year - 2020
Publication title -
radiology and oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.707
H-Index - 30
eISSN - 1581-3207
pISSN - 1318-2099
DOI - 10.2478/raon-2020-0056
Subject(s) - medicine , stage (stratigraphy) , melanoma , sentinel lymph node , dissection (medical) , lymph node , retrospective cohort study , adjuvant therapy , metastasis , surgery , lymph , cancer , chemotherapy , pathology , breast cancer , paleontology , cancer research , biology
Two prospective randomized studies analysing cutaneous melanoma (CM) patients with sentinel lymph node (SLN) metastases and rapid development of systemic adjuvant therapy have changed our approach to stage III CM treatment. The aim of this study was to compare results of retrospective survival analysis of stage III CM patients' treatment from Slovenian national CM register to leading international clinical guidelines.